Retina-Vitreous Associates Medical Group
1 clinical trials · Sponsor
◉ Watch Retina-Vitreous Associates Medical Group
| Record | Firm | Date |
|---|---|---|
| Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema (NCT02734407) | Retina-Vitreous Associates Medical Group | 2015-01-01 |
Track Retina-Vitreous Associates Medical Group automatically
Every clearance here is in the API, with alerts when new ones post.